Clinical Trial Update: ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing regadenoson with adenosine (Adenoscan) for myocardial perfusion imaging in patients with coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Adenoscan (adenosine)
• Lexiscan (regadenoson)

Snippet

Sponsor: Gilead Sciences | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED